(Q36542448)
Statements
Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization--why, when, and how? (English)
Fred R Hirsch
Marileila Varella-Garcia